Andrew Tsai

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Novo Nordisk A/S (NYSE:NVO) Wegovy. • Get the market research on VNDA stock here. The...

Shares of Marinus Pharmaceuticals Inc (NASDAQ: MRNS), a micro-cap biotech focused on therapies for neuropsychiatric disorders, are likely to see upside amid some key near-term events, according to Jefferies.  The Analyst Analyst Andrew Tsai initiated coverage of Marinus shares with a Buy...